AXIM BIOTECHNOLOGIES, INC. Cash and Restricted Cash
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Cash and Restricted Cash of $6.04 thousand as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-08-19
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.04K.
- 2024-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $96.71K.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $156.46K.
- 2023-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23.22K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2024-06-30 | $6.04K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $96.71K 10-Q/A · filed 2024-05-22 |
| 2023-12-31 | $156.46K 10-Q · filed 2024-08-19 |
| 2023-09-30 | $23.22K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $97.50K 10-Q · filed 2024-08-19 |
| 2023-03-31 | $53.54K 10-Q/A · filed 2024-05-22 |
| 2022-12-31 | $47.28K 10-Q · filed 2024-08-19 |
| 2022-09-30 | $163.75K 10-Q · filed 2023-11-20 |
| 2022-06-30 | $65.16K 10-Q · filed 2023-08-21 |
| 2022-03-31 | $408.04K 10-Q · filed 2023-05-22 |
| 2021-12-31 | $452.96K 10-K · filed 2024-04-16 |
| 2021-09-30 | $338.38K 10-Q/A · filed 2022-11-15 |
| 2020-12-31 | $457.18K 10-K · filed 2023-04-17 |